ESCONDIDO, Calif., Aug. 27, 2020 /PRNewswire/ — Marijuana Company of America Inc. (“MCOA” or the “Company“) (OTCQB: MCOA), an innovative hemp and cannabis corporation, announced today that in an effort to create awareness of the Company’s recent developments and increase in business activities, it has retained the services of Investor Awareness, Inc. as its investor relations firm .
Founded in 1994, Chicago-based Investor Awareness, Inc., (www.investorawareness.com) is a full-service investor relations consulting firm that provides private and publicly traded companies with customized programs to generate awareness among members of the financial community. Investor Awareness specializes in accelerating growth in the value of small to mid-size companies.
Jesus M. Quintero, CEO and CFO of the Company states, “Investor Awareness, Inc. will play an integral role in ensuring we reach the investment community for the first time in a professional manner in order to raise awareness of the many developments and milestones being achieved at Marijuana Company of America Inc. We are looking forward to the professional help and guidance that Investor Awareness, Inc. will provide us. Since they specialize in small to mid-cap, publicly traded companies, Investor Awareness understands the limitations smaller companies typically face with reaching the appropriate professional investors, and can guide us towards the best opportunities through a customized strategy for our particular needs.”
About Marijuana Company of America, Inc.
MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.
About our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.